Every year, I return to the professional aesthetics conference floor not as a consumer, but as a student of the industry. What was once called the International Esthetics, Cosmetics, & Spa Show and the International Beauty show has since been reimagined as the Be+Well | Beauty and Wellness Show, but its purpose has not changed: it is the place where the beauty industry shows its hand before the public ever knows what is coming.
It’s where clinics, estheticians, brands, and educators travel from across the country to learn more about the aesthetic industry. It is full of brands setting up floors of devices, protocols, and peer-reviewed data, educators lead classes, and practitioners test products. For someone like me, a trend forecaster and beauty intelligence researcher, it is one of the most valuable two days of the professional calendar. What I see on that floor today is what your aesthetician will offer you in the next twelve to twenty-four months.
This year, the story was clear. There’s a movement from treating the skin on the outside to being treated from the inside out. It is a centering of regenerative protocol versus correction-centered methodologies. Other countries’ brands are coming to the US to sell and educate through these industry events. It’s more biologically sound versus surface level aesthetics. Here are: are the seven trends that stopped me on the floor.
Ozempic Skin Is Now a Clinical Category
GLP-1 agonists, the class of medications behind Ozempic, Wegovy, and similar weight-loss drugs, are reshaping what patients look like when they walk into clinics. Rapid fat loss is revealing a specific constellation of skin changes: facial deflation, deep wrinkles, dehydration, and loss of skin density. The industry has a name for it now — Ozempic face.
What struck me on the floor was not the problem itself but the speed at which the professional market has moved to address it. IMAGE Skincare created a new product called Volu.Lift, which addressed GLP-1 skin care concerns with a full clinical booklet, the education of the product, claims, and before-and-afters. Their topical complex is formulated with L-Ornithine amino acid, HA Silanol, Bakuchiol, plant collagen fragments, and Kangaroo Paw plant extract, designed specifically to counteract the 4D skin changes that come with GLP-1 use: deflation, deep wrinkles, dehydration, and density loss.
The consumer data inside that booklet was the most significant number I encountered all weekend. GLP-1 users are visiting medspas at a rate 338% higher than non-users. They spend 63% more annually on skincare services. This is not a niche concern. It is a new client profile that every clinic and every informed beauty consumer needs to understand. Other brands I have seen on the radar are Dr. Julius Few’s Dr. Few Skincare brand, with their product: DermaReverse.
Watch for: Clinics building dedicated Ozempic skin protocols. A new category of topical products formulated for post-weight-loss facial restoration. Conversations shifting from “anti-aging” to “skin rebound.”
Exosomes and Plant Stem Cell Technology Are Rewriting Regeneration
Collagen was the story of the last decade. Now, exosomes are the story of this one. These microscopic vesicles, derived from plant or human stem cells, carry biological information that instructs the skin to repair itself at a cellular level. The difference from traditional activities is not cosmetic. It is mechanistic. Exosomes do not sit on the skin. They communicate with it.
Multiple brands on the floor were presenting exosome-based technologies, but two stood out for the sophistication of their science. Belinc, a Korean medical cosmetics brand with two decades of dermatological research behind it, presented its Phytotherasome Grape, a grape-derived plant exosome extracted through a patented IPEX method. The clinical results showed meaningful improvements in skin elasticity and wrinkle reduction after just two sessions.
ThermoCeutical, another Korean professional brand, brought their NEXO line: a fifth-generation meristem plant exosome technology formulated into shot masques with clinical-grade results. Their MV12 Shot Masque pairs 17 amino acids, 12 vitamins, and Centella Asiatica leaf exosomes into a single treatment. After two weeks, clinical measurement showed a 55.38-point improvement in skin elasticity and a reduction in the appearance of deep lines.
Watch for: Exosome facials becoming a standard menu offering at high-end clinics. Consumer-facing language is shifting from “stem cell” to “exosome” as the technology becomes better understood. Plant-derived exosomes are emerging as the cleaner, more accessible alternative to human-derived variants.
Salmon DNA Is the New Hyaluronic Acid
For years, beauty consumers have flown to Seoul specifically for skin booster treatments that are not yet available in the United States. Rejuran is one of the primary reasons. Now it has arrived on American clinic floors.
Rejuran Healing Essence is a skin biostimulator derived from salmon DNA, specifically polynucleotide (PDRN) fragments that are 97% compatible with human DNA. Unlike fillers, which add volume, Rejuran works by activating the skin’s own collagen production and regenerating the extracellular matrix. It improves skin quality at the structural level: texture, tone, elasticity, and hydration. The results are visible, cumulative, and natural-looking. I’ve seen their products in my New York City eye clinic, Line of Sight, as well as their at-home skincare products.
The brand was presenting multiple SKUs on the floor, including Healing Essence, a formulation designed specifically for the delicate periorbital skin around the eyes. Given that the skin around the eye is 40% thinner than the rest of the face, this level of specificity signals where the market is going: targeted biological repair, not broad topical intervention.
Watch for: PDRN and polynucleotide treatments moving from Korean clinics into American medspa menus. Patients are beginning to request Rejuran by name. A broader consumer conversation about biostimulators as an alternative to fillers.
LED Light Therapy Has Graduated to Clinical Science
LED light therapy has existed in spas for years, largely as an add-on, a pleasant conclusion to a facial that clients enjoyed without fully understanding. That era is ending. The science of photobiomodulation, the process by which specific wavelengths of light are absorbed by the mitochondria and converted into cellular energy, is now being presented with the rigor of clinical literature. Today, the devices have caught up.
Celluma held one of the most substantial presences on the floor. Their ELITE and PRO PLUS systems are FDA-cleared across five treatment modes: acne, wrinkles, pain, hair, and body contour. The science they present is not marketing language. It centers on four critical inputs for effective light therapy: proven wavelengths, energy delivered, proximity to skin, and treatment time. Get anyone wrong, and the therapy produces no result. Get all four right, and the cellular response is measurable.
The clinical data they shared on revenue potential was equally compelling. A single-panel LED treatment priced at $25 per session, run four times a day, five days a week, generates $26,000 in annual revenue. A full-body system at $150 per session on the same schedule generates $156,000. This is why clinics are investing.
Watch for: LED light therapy being presented as a standalone clinical treatment rather than a facial enhancement. Consumers are beginning to invest in at-home LED devices that mirror clinical-grade wavelength standards. Hair restoration via LED is becoming a significant growth category.
Korean Professional Skincare Has Entered the Building
The global influence of Korean beauty on consumer skincare is not new. What is new is the arrival of Korean professional skincare in American clinics. Not the sheet masks and essences that have populated Sephora shelves for the past five years. The clinical-grade protocols, the medical cosmetics brands, and the treatments require professional training and practitioner certification to administer.
On the floor, I encountered Belinc, Rejuran, and ThermoCeutical as three distinct examples of this movement. Each brand arrives carrying decades of Korean dermatological research, advisory boards of domestic Korean dermatologists, and clinical protocols developed and refined within Korea’s famously rigorous aesthetic medicine culture. They are not adapting their products for American consumers. They are educating American practitioners in Korean methodology.
The significance of this shift cannot be overstated. For years, the most sophisticated skin treatments available to Korean women were accessible only by flying to Seoul. That access gap is closing. American clinics are now being equipped with the same products, the same protocols, and the same science. The treatment you once had to travel internationally to receive may soon be available at your local medspa.
Watch for: Korean professional brands accelerating their US market entry over the next 18 months. Practitioners completing Korean-developed certification programs. Consumer demand for K-aesthetic treatments is driving clinic investment in new protocols.
NAD+ Has Left the Wellness Space and Entered Aesthetics
NAD+ — nicotinamide adenine dinucleotide — has been a fixture of the longevity and biohacking conversation for several years. What is shifting is its presence on the professional aesthetics floor, which signals that the beauty industry is beginning to absorb cellular energy science as a legitimate tool for skin health.
Richesse presented their NAD+ Booster on the floor, a professional injectable formulated with NAD+ 120mg and NMN Activator 5ml. The science behind it centers on NAD+ as a coenzyme that drives cellular energy production. As levels decline with age, the skin’s capacity for repair and regeneration diminishes with them. Replenishing NAD+ is being positioned not as a cosmetic intervention but as a metabolic one. The skin is being treated as a biological system, not a surface.
Watch for: NAD+ injectables and topicals appearing on medspa menus alongside traditional aesthetic treatments. The language of cellular energy and metabolic aging is entering mainstream beauty conversations. Cross-category positioning between longevity medicine and professional skincare is accelerating.
The Line Between the Clinic and the Home Is Dissolving
One of the most consistent threads running through every brand I encountered was the blurring of the boundary between professional treatment and home ritual. This is not the at-home facial device story that has circulated for years. This is something more structural: professional brands deliberately engineering the at-home continuation of clinical protocols as a core part of their offering.
A great example of a luxury brand I have seen outside of this conference is Orveda. It’s a French Green Bio-Tech skincare brand that presents their three-step home ritual as the post-procedure continuation of in-clinic treatments. Their Vital Sap, Rich Brew Cream, and Overnight Reviving Mask are formulated to maintain the skin’s biological environment between professional appointments. The positioning is precise: not a replacement for clinical treatment, but the daily architecture that makes clinical results last.
The Volu.Lift GLP-1 4D Skin Rebound Complex makes the same argument from a different angle. Formulated specifically to be used at home by GLP-1 patients between clinic visits, it is a topical product built on clinical-grade actives and clinical study data. The brochure includes a 12-week clinical measurement breakdown. This is not mass-market skincare with clinical language grafted onto the packaging. This is clinical science translated into a take-home format.
Watch for: Clinics building prescribed home-care regimens as part of treatment packages. Professional brands developing consumer-facing lines that extend, not duplicate, in-clinic protocols. The informed beauty consumer is becoming a more active participant in the science of their own skin.
What This Means for You
The professional floor is always a preview. What you see there today is what your clinic will offer tomorrow, and what the mass market will eventually absorb the year after that. The seven trends above share a single organizing idea: the skin is being understood as a living biological system that can be supported, instructed, and regenerated. Not corrected. Not masked. Regenerated.
This is the direction the most sophisticated skincare in the world is moving. The question is not whether these treatments will reach you. It is how prepared you will be when they do.
